Medtronic officially spins off diabetes business to become standalone company MiniMed. Includes news of regulatory updates for the MiniMed insulin pump system.
Medtronic has announced 3 milestones that broaden MiniMed 780G hybrid-closed loop system in the USA. The news covers Medicare access, new insulin options, and an expansion to people with insulin-requiring type 2 diabetes.
Medtronic has received FDA clearance for a new mobile app called MiniMed Go, designed to connect its smart insulin pens with the Instinct sensor by Abbott.
FDA approval of Simplera Sync sensor paired with MiniMed™ 780G insulin pump.
